APA (7th ed.) Citation

J, B., MJ, B., HJ, A., J, R., M, H., U, W., & D, T. (2015). Hormone withdrawal-associated symptoms with ethinylestradiol 20 μg/drospirenone 3 mg (24/4 regimen) versus ethinylestradiol 20 μg/desogestrel 150 μg (21/7 regimen). International journal of women's health, 7, 501. https://doi.org/10.2147/IJWH.S77942

Chicago Style (17th ed.) Citation

J, Bitzer, Banal-Silao MJ, Ahrendt HJ, Restrepo J, Hardtke M, Wissinger-Graefenhahn U, and Trummer D. "Hormone Withdrawal-associated Symptoms with Ethinylestradiol 20 μg/drospirenone 3 Mg (24/4 Regimen) Versus Ethinylestradiol 20 μg/desogestrel 150 μg (21/7 Regimen)." International Journal of Women's Health 7 (2015): 501. https://doi.org/10.2147/IJWH.S77942.

MLA (9th ed.) Citation

J, Bitzer, et al. "Hormone Withdrawal-associated Symptoms with Ethinylestradiol 20 μg/drospirenone 3 Mg (24/4 Regimen) Versus Ethinylestradiol 20 μg/desogestrel 150 μg (21/7 Regimen)." International Journal of Women's Health, vol. 7, 2015, p. 501, https://doi.org/10.2147/IJWH.S77942.